Vcanbio Cell & Gene Engineering Co., Ltd. (600645)

Overview

Vcanbio Cell & Gene Engineering Corp., Ltd is a notable entity in the biotechnology sector, having established its presence in the People’s Republic of China since 1992. With a comprehensive network of subsidiaries, the company specializes in a range of biological research, development, and service provision. Its core operations include the preparation and storage of various types of cell detection tests, playing a pivotal role in the biotechnological and healthcare industries within China. Based in Tianjin, Vcanbio is at the forefront of offering advanced genetic testing services and developing biotechnological products that cater to diverse medical and research requirements.

Products and Services

The products and services offered by Vcanbio Cell & Gene Engineering Corp., Ltd are integral to their mission of advancing biological and healthcare solutions. These include:

• Cell Test Preparation and Storage Services: The company is adept at managing the preparation and storage of key stem cells, including umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. These services are crucial for medical research and various therapeutic applications.
• Genetic Testing Services: A broad array of genetic testing services are provided, including non-invasive prenatal genetic testing during pregnancy, which offers expectant parents insights into the genetic health of their unborn child. Additionally, the company provides genetic testing for drug safety guidance, disease genetic testing, and disease susceptibility testing for both children and adults, facilitating personalized medicine and preventative health strategies.
• In Vitro Diagnostic Raw Materials: Vcanbio produces in vitro diagnostic raw materials such as monoclonal and polyclonal antibody products. These materials are foundational in developing diagnostic tests and research in immunology and other biological fields.
• Biological Genes, Proteins, Antibodies, and Pharmaceutical Intermediates: The company’s involvement in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and synthetic agents keys into the larger biotechnological ecosystem, supporting research and development across a wide spectrum of life sciences.
• In Vitro Diagnostic Reagents and Medical Devices: Vcanbio also manufactures in vitro diagnostic reagents and medical devices, broadening their support for healthcare providers and researchers with tools necessary for diagnostics and patient care.